<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36068612</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study.</ArticleTitle><Pagination><StartPage>218</StartPage><MedlinePgn>218</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">218</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-022-02582-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Triggering receptor expressed on myeloid cell 1 (Trem1) is an important regulator of cellular inflammatory responses. Neuroinflammation is a common thread across various neurological diseases. Soluble Trem1 (sTrem1) in plasma is associated with the development of central nervous system disorders. However, the extent of any causative effects of plasma sTrem1 on the risk of these disorders is still unclear.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Genetic variants for plasma sTrem1 levels were selected as instrumental variables. Summary-level statistics of neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), epilepsy, cerebrovascular diseases, and migraine were collected from genome-wide association studies (GWASs). Whether plasma sTrem1 was causally associated with neurological disorders was assessed using a two-sample Mendelian randomization (MR) analysis, with false discovery rate (FDR)-adjusted methods applied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We inferred suggestive association of higher plasma sTrem1 with the risk of AD (odds ratio [OR] per one standard deviation [SD] increase&#x2009;=&#x2009;1.064, 95% CI 1.012-1.119, P&#x2009;=&#x2009;0.014, P<sub>FDR</sub>&#x2009;=&#x2009;0.056). Moreover, there was significant association between plasma sTrem1 level and the risk of epilepsy (OR per one SD increase&#x2009;=&#x2009;1.044, 95% CI 1.016-1.072, P&#x2009;=&#x2009;0.002, P<sub>FDR</sub>&#x2009;=&#x2009;0.032), with a modest statistical power of 41%. Null associations were found for plasma sTrem1 with other neurological diseases and their subtypes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Taken together, this study indicates suggestive association between plasma sTrem1 and AD. Moreover, higher plasma sTrem1 was associated with the increased risk of epilepsy. The findings support the hypothesis that sTrem1 may be a vital element on the causal pathway to AD and epilepsy.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Geriatric Neuroscience Center, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wei</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders, Department of Neurology, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yachun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders, Department of Neurology, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Innovation Center for Neurological Disorders, Department of Neurology, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China. tangyi@xwhosp.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Laboratory of Ministry of Education of the Peoples Republic of China, Beijing, China. tangyi@xwhosp.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021-2023</GrantID><Agency>Guangzhou Municipal Key Discipline in Medicine</Agency><Country/></Grant><Grant><GrantID>2019B030316001</GrantID><Agency>Science and Technology Plan Project of Guangdong Province</Agency><Country/></Grant><Grant><GrantID>JQ19024</GrantID><Agency>Beijing Natural Science Foundation</Agency><Country/></Grant><Grant><GrantID>81970996</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>Z191100006619046</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant><Grant><GrantID>DFL20220703</GrantID><Agency>Beijing Hospitals Authority's Ascent Plan</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C408842">TREM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073871">Triggering Receptor Expressed on Myeloid Cells-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073871" MajorTopicYN="N">Triggering Receptor Expressed on Myeloid Cells-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Epilepsy</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Neurological diseases</Keyword><Keyword MajorTopicYN="N">sTrem1</Keyword></KeywordList><CoiStatement>There was no conflict of interests among the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>6</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36068612</ArticleId><ArticleId IdType="pmc">PMC9446564</ArticleId><ArticleId IdType="doi">10.1186/s12974-022-02582-z</ArticleId><ArticleId IdType="pii">10.1186/s12974-022-02582-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimer's Dementia. 2018;4:575&#x2013;590. doi: 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType="pmc">PMC6214864</ArticleId><ArticleId IdType="pubmed">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Brambilla R. Neuroinflammation, the thread connecting neurological disease. Acta Neuropathol. 2019;137(5):689&#x2013;691. doi: 10.1007/s00401-019-02009-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02009-9</ArticleId><ArticleId IdType="pubmed">30968314</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase S, Linker RA. Inflammation in multiple sclerosis. Ther Adv Neurol Disord. 2021;14:17562864211007687. doi: 10.1177/17562864211007687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562864211007687</ArticleId><ArticleId IdType="pmc">PMC8053832</ArticleId><ArticleId IdType="pubmed">33948118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Leak RK, Thomson AW, Yu F, Xia Y, Wechsler LR, Chen J. Promises and limitations of immune cell-based therapies in neurological disorders. Nat Rev Neurol. 2018;14(9):559&#x2013;568. doi: 10.1038/s41582-018-0028-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0028-5</ArticleId><ArticleId IdType="pmc">PMC6237550</ArticleId><ArticleId IdType="pubmed">29925925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 2003;170(7):3812&#x2013;3818. doi: 10.4049/jimmunol.170.7.3812.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.7.3812</ArticleId><ArticleId IdType="pubmed">12646648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991&#x2013;4995. doi: 10.4049/jimmunol.164.10.4991.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.10.4991</ArticleId><ArticleId IdType="pubmed">10799849</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81&#x2013;95. doi: 10.1016/j.pharmthera.2017.02.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2017.02.043</ArticleId><ArticleId IdType="pubmed">28245991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Liu R, Sherchan P, Ren R, He W, Fang Y, Huang Y, Shi H, Tang L, Yang S, et al. TREM (Triggering Receptor Expressed on Myeloid Cells)-1 inhibition attenuates neuroinflammation via PKC (Protein Kinase C) &amp; CARD9 (Caspase Recruitment Domain Family Member 9) signaling pathway after intracerebral hemorrhage in mice. Stroke. 2021;52(6):2162&#x2013;2173. doi: 10.1161/STROKEAHA.120.032736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032736</ArticleId><ArticleId IdType="pmc">PMC8321132</ArticleId><ArticleId IdType="pubmed">33947214</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy EJ. Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists. Recent Pat Anti-Infect Drug Discov. 2009;4(1):51&#x2013;56. doi: 10.2174/157489109787236292.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157489109787236292</ArticleId><ArticleId IdType="pubmed">19149696</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Zhang Y-D, Gao Q, Zhou J-S, Zhu X-C, Lu H, Shi J-Q, Tan L, Chen Q, Yu J-T. TREM1 facilitates microglial phagocytosis of amyloid beta. Acta Neuropathol. 2016;132(5):667&#x2013;683. doi: 10.1007/s00401-016-1622-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1622-5</ArticleId><ArticleId IdType="pubmed">27670763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Zhang X, Liu Q, Xie Y, Shi X, Chen J, Li Y, Guo H, Sun R, Hong Y. Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. Cell Death Dis. 2019;10(8):1&#x2013;17. doi: 10.1038/s41419-019-1777-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1777-9</ArticleId><ArticleId IdType="pmc">PMC6642102</ArticleId><ArticleId IdType="pubmed">31324751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Gong P-Y, Tan M-S, Xue X, Huang S, Zhou J-S, Tan L, Zhang Y-D. Soluble TREM1 concentrations are increased and positively correlated with total tau levels in the plasma of patients with Alzheimer&#x2019;s disease. Aging Clin Exp Res. 2019;31(12):1801&#x2013;1805. doi: 10.1007/s40520-019-01122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-019-01122-9</ArticleId><ArticleId IdType="pubmed">30637597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hok-A-Hin YS, van der Flier WM, Lemstra AW, Del Campo M, Teunissen CE. Novel CSF inflammatory markers MIF and TREM-1 are increased in Alzheimer&#x2019;s disease. Alzheimers Dement. 2021;17:e055184.</Citation></Reference><Reference><Citation>Buckland KF, Ramaprakash H, Murray LA, Carpenter KJ, Choi ES, Kunkel SL, Lukacs NW, Xing Z, Aoki N, Hartl D. Triggering receptor expressed on myeloid cells-1 (TREM-1) modulates immune responses to Aspergillus fumigatus during fungal asthma in mice. Immunol Invest. 2011;40(7&#x2013;8):692&#x2013;722. doi: 10.3109/08820139.2011.578270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08820139.2011.578270</ArticleId><ArticleId IdType="pmc">PMC5540193</ArticleId><ArticleId IdType="pubmed">21592044</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh JW, Lim C-M, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Hong S-B. Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care. 2008;12(1):1&#x2013;7. doi: 10.1186/cc6770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6770</ArticleId><ArticleId IdType="pmc">PMC2374623</ArticleId><ArticleId IdType="pubmed">18205941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Wang F, Fan X, Bao R, Bo L, Li J, Deng X. Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care. 2012;16(6):1&#x2013;11. doi: 10.1186/cc11884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11884</ArticleId><ArticleId IdType="pmc">PMC3672614</ArticleId><ArticleId IdType="pubmed">23194114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait Oufella H, Gibot S, Danchin N, Derive M, Kotti S, Lemarie J, Ohlmann P, Heitz A, Joffre J, Darchis J. circulating levels of sTREM-1 and mortality in patients with an acute myocardial infarction. Circulation. 2014;130(suppl_2):A16204.</Citation></Reference><Reference><Citation>Sun X-G, Ma Q, Jing G, Wang L, Hao X-D, Wang G-Q. Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients. Neurol Sci. 2017;38(5):873&#x2013;877. doi: 10.1007/s10072-017-2853-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-2853-5</ArticleId><ArticleId IdType="pubmed">28229304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133&#x2013;1163. doi: 10.1002/sim.3034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25(5):1394&#x2013;1398. doi: 10.1093/ndt/gfq098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq098</ArticleId><ArticleId IdType="pubmed">20190244</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925&#x2013;1926. doi: 10.1001/jama.2017.17219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17219</ArticleId><ArticleId IdType="pubmed">29164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73&#x2013;79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414&#x2013;430. doi: 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091&#x2013;1102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;1283. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, Wong G, Beecham AH, James T, Replogle J, Vlachos IS, et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188. doi: 10.1126/science.aav7188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav7188</ArticleId><ArticleId IdType="pmc">PMC7241648</ArticleId><ArticleId IdType="pubmed">31604244</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Khalil B, Auce P, Avbersek A, Bahlo M, Balding DJ, Bast T, Baum L, Becker AJ, Becker F, Berghuis B, et al. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018;9(1):5269. doi: 10.1038/s41467-018-07524-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07524-z</ArticleId><ArticleId IdType="pmc">PMC6288131</ArticleId><ArticleId IdType="pubmed">30531953</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524&#x2013;537. doi: 10.1038/s41588-018-0058-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0058-3</ArticleId><ArticleId IdType="pmc">PMC5968830</ArticleId><ArticleId IdType="pubmed">29531354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei T, Guo Z, Wang Z, Li C, Zhu W, Zheng Y, Yin Y, Mi Y, Xia X, Hou H, Tang Y. Five major psychiatric disorders and Alzheimer's disease: a bidirectional mendelian randomization study. J Alzheimers Dis. 2022;87(2):675&#x2013;684. doi: 10.3233/JAD-220010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220010</ArticleId><ArticleId IdType="pubmed">35367968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z, Yang R, Wang W, Qi L, Huang T. Associations between gut microbiota and Alzheimer's disease, major depressive disorder, and schizophrenia. J Neuroinflamm. 2020;17(1):288. doi: 10.1186/s12974-020-01961-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01961-8</ArticleId><ArticleId IdType="pmc">PMC7532639</ArticleId><ArticleId IdType="pubmed">33008395</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497&#x2013;1501. doi: 10.1093/ije/dyt179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt179</ArticleId><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, Paul DS, Freitag D, Burgess S, Danesh J, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32(20):3207&#x2013;3209. doi: 10.1093/bioinformatics/btw373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw373</ArticleId><ArticleId IdType="pmc">PMC5048068</ArticleId><ArticleId IdType="pubmed">27318201</ArticleId></ArticleIdList></Reference><Reference><Citation>MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) Nucleic Acids Res. 2017;45(D1):D896&#x2013;d901. doi: 10.1093/nar/gkw1133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1133</ArticleId><ArticleId IdType="pmc">PMC5210590</ArticleId><ArticleId IdType="pubmed">27899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, Hartwig FP, Holmes MV, Minelli C, Relton CL, Theodoratou E. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2019;4:186. doi: 10.12688/wellcomeopenres.15555.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15555.1</ArticleId><ArticleId IdType="pmc">PMC7384151</ArticleId><ArticleId IdType="pubmed">32760811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;314. doi: 10.1002/gepi.21965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985&#x2013;1998. doi: 10.1093/ije/dyx102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx102</ArticleId><ArticleId IdType="pmc">PMC5837715</ArticleId><ArticleId IdType="pubmed">29040600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi: 10.7554/eLife.34408.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34408</ArticleId><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;698. doi: 10.1038/s41588-018-0099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett. 2008;116(2):111&#x2013;116. doi: 10.1016/j.imlet.2007.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2007.11.021</ArticleId><ArticleId IdType="pubmed">18192027</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos AO, Dantas PHS, Silva-Sales M, Sales-Campos H. TREM-1 isoforms in bacterial infections: to immune modulation and beyond. Crit Rev Microbiol. 2021;47(3):290&#x2013;306. doi: 10.1080/1040841X.2021.1878106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2021.1878106</ArticleId><ArticleId IdType="pubmed">33522328</ArticleId></ArticleIdList></Reference><Reference><Citation>Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol. 2006;7(12):1266&#x2013;1273. doi: 10.1038/ni1411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1411</ArticleId><ArticleId IdType="pubmed">17110943</ArticleId></ArticleIdList></Reference><Reference><Citation>Menyhart O, Weltz B, Gy&#x151;rffy B. MultipleTesting.com: a tool for life science researchers for multiple hypothesis testing correction. PLoS ONE. 2021;16(6):e0245824. doi: 10.1371/journal.pone.0245824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245824</ArticleId><ArticleId IdType="pmc">PMC8189492</ArticleId><ArticleId IdType="pubmed">34106935</ArticleId></ArticleIdList></Reference><Reference><Citation>Korthauer K, Kimes PK, Duvallet C, Reyes A, Subramanian A, Teng M, Shukla C, Alm EJ, Hicks SC. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20(1):118. doi: 10.1186/s13059-019-1716-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1716-1</ArticleId><ArticleId IdType="pmc">PMC6547503</ArticleId><ArticleId IdType="pubmed">31164141</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Delatour B, Potier M-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118(1):5&#x2013;36. doi: 10.1007/s00401-009-0532-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. &#x3b2;-amyloid1&#x2013;42 induces neuronal death through the p75 neurotrophin receptor. J Neurosci. 2008;28(15):3941&#x2013;3946. doi: 10.1523/JNEUROSCI.0350-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0350-08.2008</ArticleId><ArticleId IdType="pmc">PMC6670462</ArticleId><ArticleId IdType="pubmed">18400893</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS, Mattsson N, Donohue MC, Mackin RS, Aisen PS, Jack CR, Jr, Shaw LM, Trojanowski JQ, Weiner MW, Initiative AsDN Initiative AsDN The transitional association between &#x3b2;-amyloid pathology and regional brain atrophy. Alzheimers Dement. 2015;11(10):1171&#x2013;1179. doi: 10.1016/j.jalz.2014.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.11.002</ArticleId><ArticleId IdType="pmc">PMC4461550</ArticleId><ArticleId IdType="pubmed">25499535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood H. Sequential amyloid-&#x3b2; and tau accumulation foreshadows cognitive decline. Nat Rev Neurol. 2019;15(8):433&#x2013;433. doi: 10.1038/s41582-019-0230-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0230-0</ArticleId><ArticleId IdType="pubmed">31217578</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalivaeva NN, Turner AJ. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy. Br J Pharmacol. 2019;176(18):3447&#x2013;3463. doi: 10.1111/bph.14593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14593</ArticleId><ArticleId IdType="pmc">PMC6715594</ArticleId><ArticleId IdType="pubmed">30710367</ArticleId></ArticleIdList></Reference><Reference><Citation>Replogle JM, Chan G, White CC, Raj T, Winn PA, Evans DA, Sperling RA, Chibnik LB, Bradshaw EM, Schneider JA. A TREM 1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015;77(3):469&#x2013;477. doi: 10.1002/ana.24337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24337</ArticleId><ArticleId IdType="pmc">PMC4461024</ArticleId><ArticleId IdType="pubmed">25545807</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-S, Yan W-J, Tan C-C, Li J-Q, Xu W, Cao X-P, Tan L, Yu J-T. Common variant in TREM1 influencing brain amyloid deposition in mild cognitive impairment and Alzheimer&#x2019;s disease. Neurotox Res. 2020;37(3):661&#x2013;668. doi: 10.1007/s12640-019-00105-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-019-00105-y</ArticleId><ArticleId IdType="pubmed">31721052</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood CJ, Cooper JD, Hanger DP, Noble W. Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psych. 2010;1:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059645</ArticleId><ArticleId IdType="pubmed">21423446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kima M-KLMS. Associations among the TREM-1 pathway, tau hyperphosphorylation, prolactin expression, and metformin in diabetes mice. NeuroImmunoModulation. 2022 doi: 10.1159/000521013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521013</ArticleId><ArticleId IdType="pubmed">35130556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the stigma of a chronic neurological disorder. Lancet Neurol. 2005;4(3):171&#x2013;178. doi: 10.1016/S1474-4422(05)70020-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70020-X</ArticleId><ArticleId IdType="pubmed">15721827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflamm. 2018;15(1):1&#x2013;12. doi: 10.1186/s12974-018-1192-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1192-7</ArticleId><ArticleId IdType="pmc">PMC5952578</ArticleId><ArticleId IdType="pubmed">29764485</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirico-Santos T, Mello AN, Gomes AC, de Carvalho LP, de Souza JM, Alves-Leon S. Increased metalloprotease activity in the epileptogenic lesion&#x2014;lobectomy reduces metalloprotease activity and urokinase-type uPAR circulating levels. Brain Res. 2013;1538:172&#x2013;181. doi: 10.1016/j.brainres.2013.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.09.044</ArticleId><ArticleId IdType="pubmed">24095794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(7):S10&#x2013;S17. doi: 10.1038/nm1066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol. 2005;6(11):891&#x2013;898. doi: 10.1038/nrm1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1742</ArticleId><ArticleId IdType="pubmed">16167052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucot K, Stevens M, Jain P, Bonham T, Webber E, Klockow J, Azevedo EC, Chaney A, Graves E, Montine T. Visualizing innate immune activation in a mouse model of Parkinson&#x2019;s disease using a highly specific TREM1-PET tracer. Soc Nuclear Med. 2020 doi: 10.2967/jnumed.121.263039.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.263039</ArticleId><ArticleId IdType="pubmed">35177426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaney A, Wilson E, Jain P, Cropper H, Swarovski M, Lucot K, Vogel H, Andreasson K, James ML: TREM1-PET imaging of pro-inflammatory myeloid cells distinguishes active disease from remission in Multiple Sclerosis. Soc Nuclear Med; 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>